Deals this week: Thriva Limited, Centogene, Art Medical

15 June 2017 (Last Updated June 15th, 2017 18:30)

Thriva Limited has raised £1.5m ($1.9m) in seed funding from US-based venture capital firm 500 Startups Management LLC.

Thriva Limited has raised £1.5m ($1.9m) in seed funding from US-based venture capital firm 500 Startups Management LLC.

The UK-based digital health company plans to use the funds for expanding its product offerings.

Centogene AG has secured €25m ($28.02m) through a Series A financing round led by TVM Capital Life Science.

The German diagnostics company Centogene intends to expand its business segments with the funds.

Art Medical Ltd has secured $20m in a financing round led by Advanced Medical Technologies LLC.

"The minimally invasive treatments developer intends to use the funds to commercialise its patented mild procedure and also provide physician training and education."

Based in Israel, Art Medical specialises in providing smart tubes for patients in ICU.

GenMark Diagnostics Inc has announced a public offering of shares to raise $65m.

The US-based multiplex molecular diagnostic testing systems provider plans to use the stocks for general corporate purposes and to carry out research and development activities.

Vertos Medical Inc has secured $28m in a venture financing round led by MVM Life Science Partners.

The minimally invasive treatments developer intends to use the funds to commercialise its patented mild procedure and also provide physician training and education.